Blockade of LIGHT as a way of IBD treatment has not been tested in clinical settings, although administration of anti-LIGHT antibodies reduced symptoms of DSS-induced colon inflammation in mice [176]. This evidence concerns the gene TNFSF14 and inflammatory bowel disease.